These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 28679413)

  • 1. Double carbapenem as a rescue strategy for the treatment of severe carbapenemase-producing Klebsiella pneumoniae infections: a two-center, matched case-control study.
    De Pascale G; Martucci G; Montini L; Panarello G; Cutuli SL; Di Carlo D; Di Gravio V; Di Stefano R; Capitanio G; Vallecoccia MS; Polidori P; Spanu T; Arcadipane A; Antonelli M
    Crit Care; 2017 Jul; 21(1):173. PubMed ID: 28679413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro evaluation of different antimicrobial combinations against carbapenemase-producing Klebsiella pneumoniae: the activity of the double-carbapenem regimen is related to meropenem MIC value.
    Oliva A; Scorzolini L; Cipolla A; Mascellino MT; Cancelli F; Castaldi D; D'Abramo A; D'Agostino C; Russo G; Ciardi MR; Mastroianni CM; Vullo V
    J Antimicrob Chemother; 2017 Jul; 72(7):1981-1984. PubMed ID: 28369424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bactericidal and synergistic activity of double-carbapenem regimen for infections caused by carbapenemase-producing Klebsiella pneumoniae.
    Oliva A; Gizzi F; Mascellino MT; Cipolla A; D'Abramo A; D'Agostino C; Trinchieri V; Russo G; Tierno F; Iannetta M; Mastroianni CM; Vullo V
    Clin Microbiol Infect; 2016 Feb; 22(2):147-153. PubMed ID: 26409059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of carbapenem-resistant Klebsiella pneumoniae (CR-KP) infections in kidney transplantation.
    Varotti G; Dodi F; Terulla A; Santori G; Mariottini G; Bertocchi M; Marchese A; Fontana I
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28796391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae.
    Wu D; Cai J; Liu J
    South Med J; 2011 Feb; 104(2):106-10. PubMed ID: 21258230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of colistin resistance and other predictors on fatality among patients with bloodstream infections due to Klebsiella pneumoniae in an OXA-48 dominant region.
    Menekşe Ş; Çağ Y; Işık ME; Şahin S; Hacıseyitoğlu D; Can F; Ergonul O
    Int J Infect Dis; 2019 Sep; 86():208-211. PubMed ID: 31402295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment outcome of non-carbapenemase-producing carbapenem-resistant Klebsiella pneumoniae infections: a multicenter study in Taiwan.
    Su CF; Chuang C; Lin YT; Chan YJ; Lin JC; Lu PL; Huang CT; Wang JT; Chuang YC; Siu LK; Fung CP
    Eur J Clin Microbiol Infect Dis; 2018 Apr; 37(4):651-659. PubMed ID: 29238934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study.
    Tumbarello M; Trecarichi EM; De Rosa FG; Giannella M; Giacobbe DR; Bassetti M; Losito AR; Bartoletti M; Del Bono V; Corcione S; Maiuro G; Tedeschi S; Celani L; Cardellino CS; Spanu T; Marchese A; Ambretti S; Cauda R; Viscoli C; Viale P;
    J Antimicrob Chemother; 2015 Jul; 70(7):2133-43. PubMed ID: 25900159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbapenem-resistant and carbapenem-susceptible isogenic isolates of Klebsiella pneumoniae ST101 causing infection in a tertiary hospital.
    Cubero M; Cuervo G; Dominguez MÁ; Tubau F; Martí S; Sevillano E; Gallego L; Ayats J; Peña C; Pujol M; Liñares J; Ardanuy C
    BMC Microbiol; 2015 Sep; 15():177. PubMed ID: 26335352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection.
    Giannella M; Trecarichi EM; Giacobbe DR; De Rosa FG; Bassetti M; Bartoloni A; Bartoletti M; Losito AR; Del Bono V; Corcione S; Tedeschi S; Raffaelli F; Saffioti C; Spanu T; Rossolini GM; Marchese A; Ambretti S; Cauda R; Viscoli C; Lewis RE; Viale P; Tumbarello M;
    Int J Antimicrob Agents; 2018 Feb; 51(2):244-248. PubMed ID: 28842283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment Outcome of Bacteremia Due to Non-Carbapenemase-producing Carbapenem-Resistant Klebsiella pneumoniae Bacteremia: Role of Carbapenem Combination Therapy.
    Lee NY; Tsai CS; Syue LS; Chen PL; Li CW; Li MC; Ko WC
    Clin Ther; 2020 Mar; 42(3):e33-e44. PubMed ID: 32061374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infections caused by carbapenem-resistant Klebsiella pneumoniae among patients in intensive care units in Greece: a multi-centre study on clinical outcome and therapeutic options.
    Kontopidou F; Giamarellou H; Katerelos P; Maragos A; Kioumis I; Trikka-Graphakos E; Valakis C; Maltezou HC;
    Clin Microbiol Infect; 2014 Feb; 20(2):O117-23. PubMed ID: 23992130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality Associated with Bacteremia Due to Colistin-Resistant Klebsiella pneumoniae with High-Level Meropenem Resistance: Importance of Combination Therapy without Colistin and Carbapenems.
    Machuca I; Gutiérrez-Gutiérrez B; Gracia-Ahufinger I; Rivera Espinar F; Cano Á; Guzmán-Puche J; Pérez-Nadales E; Natera C; Rodríguez M; León R; Castón JJ; Rodríguez-López F; Rodríguez-Baño J; Torre-Cisneros J
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical Review of Double-Carbapenem Therapy for the Treatment of Carbapenemase-Producing Klebsiella pneumoniae.
    Mashni O; Nazer L; Le J
    Ann Pharmacother; 2019 Jan; 53(1):70-81. PubMed ID: 30019911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.
    Falcone M; Russo A; Iacovelli A; Restuccia G; Ceccarelli G; Giordano A; Farcomeni A; Morelli A; Venditti M
    Clin Microbiol Infect; 2016 May; 22(5):444-50. PubMed ID: 26850826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors for Carbapenem-resistant
    Wang Z; Qin RR; Huang L; Sun LY
    Chin Med J (Engl); 2018 Jan; 131(1):56-62. PubMed ID: 29271381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology, management, and outcome of carbapenem-resistant Klebsiella pneumoniae bloodstream infections in hospitals within the same endemic metropolitan area.
    Cristina ML; Alicino C; Sartini M; Faccio V; Spagnolo AM; Bono VD; Cassola G; De Mite AM; Crisalli MP; Ottria G; Schinca E; Pinto GL; Bottaro LC; Viscoli C; Orsi A; Giacobbe DR; Icardi G;
    J Infect Public Health; 2018; 11(2):171-177. PubMed ID: 28668656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections.
    Neuner EA; Yeh JY; Hall GS; Sekeres J; Endimiani A; Bonomo RA; Shrestha NK; Fraser TG; van Duin D
    Diagn Microbiol Infect Dis; 2011 Apr; 69(4):357-62. PubMed ID: 21396529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular epidemiology and drug resistant mechanism in carbapenem-resistant Klebsiella pneumoniae isolated from pediatric patients in Shanghai, China.
    Zhang X; Chen D; Xu G; Huang W; Wang X
    PLoS One; 2018; 13(3):e0194000. PubMed ID: 29558475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for infections due to carbapenem-resistant Klebsiella pneumoniae after open heart surgery.
    Salsano A; Giacobbe DR; Sportelli E; Olivieri GM; Brega C; Di Biase C; Coppo E; Marchese A; Del Bono V; Viscoli C; Santini F
    Interact Cardiovasc Thorac Surg; 2016 Nov; 23(5):762-768. PubMed ID: 27371609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.